Introduction {#sec1}
============

As an example of a triheterocyclic system, pyridothienopyrimidine has interesting biological activities among its derivatives which have attracted much attention. Pyridothienopyrimidines are a special class of thienopyridine derivatives. There are two regioisomeric structures, namely, 5*H*-thieno\[2,3,4-*e*,*d*\]pyrido\[4,3-*d*\]pyrimidine ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A) or pyrido\[3′,2′:4,5\] thieno\[3,2-*d*\]pyrimidine ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B). These two structures give all pyridothienopyrimidine derivatives which are prepared by annulation of thieno\[2,3-*b*\] pyridines.^[@ref1]^

![Chemical structures of 5*H*-thieno\[2,3,4-*e*,*d*\]pyrido\[4,3-*d*\]pyrmidine (A) and pyrido\[3′,2′:4,5\] thieno\[3,2-*d*\]pyrimidine (B).](ao0c00188_0001){#fig1}

Among all fused thienoazines, pyridothienopyrimidine derivatives have been studied the most. These derivatives act as bactericides^[@ref2]−[@ref6]^ fungicides,^[@ref2]−[@ref6]^ antiprotozoals,^[@ref7]^ or immunomodulators; exhibit antianaphylactic, antiallergic,^[@ref8]^ anticonvulsive,^[@ref9]^ analgetic, or anti-inflammatory activities;^[@ref10],[@ref11]^ and are used as intermediate products in chemical pharmaceutical industry.^[@ref1]^

In addition to antimicrobial,^[@ref2]−[@ref6]^ anticonvulsant,^[@ref9]^ and anticancer activities^[@ref12]−[@ref17]^ of pyridothienopyrimidine derivatives, recent studies showed that they have the ability to specifically activate testicular steroidogenesis without affecting thyroid functions.^[@ref18]^ They also have inhibitory effects on some closely linked factors to human malignancies such as cellular mesenchymal--epithelial transition factor;^[@ref19]^ the Moloney murine leukemia virus-1 (pim-1)^[@ref20]^ proviral integration site; some signaling pathways that play an important role in tumorigenesis;^[@ref21]^ VEGFR-2 receptors to reduce angiogenesis or lymphangiogenesis;^[@ref22]^ and act as alpha-1 blockers^[@ref23]^ that are mainly used as a prescribed drugs for benign prostatic hyperplasia, manage hypertension, and treatment of posttraumatic stress disorder.

Within this respect, the current study has aimed to examine the chemistry of 4-hydrazino-7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidine^[@ref24]^ to be used as a starting material for the synthesis of some new pyrazole, pyrazolopyrimidine, and thiazole derivatives and investigate their antibacterial activities.

Results and Discussion {#sec2}
======================

Ethoxymethylene malononitrile and 4-hydrazino-7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidine (**1**) were refluxed in absolute ethanol to give 5-amino-1-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-1*H*-pyrazole-4-carbonitrile (**2**) in 58% yield. Nitrile derivative (**2**) was refluxed in 80% formic acid and/or acetic acid to afford 1-(7,9-dimethylpyrido\[3′,2′:4,5\] thieno\[3,2-*d*\]pyrimidin-4-yl)-1,5-dihydro-4*H*-pyrazolo\[3,4-*d*\]pyrimidin-4-one (**3**) and 1-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-6-methyl-1,5-dihydro-4*H*-pyrazolo\[3,4-*d*\]pyrimidin-4-one (**4**), respectively. A mixture of ethoxymethylene cyanoactate and (**1**) was refluxed in absolute ethanol to give 2-(7,9-dimethylpyrido \[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carbonitrile (**5**) in 72% yield. Acid hydrolysis occurred for (**5**) which was refluxed in 10% sulfuric acid to give 2-(7,9-dimethylpyrido \[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carboxylic acid (**6**) in 41% yield. Diethyl ethoxymethylenemalonate and (**1**) were refluxed in absolute ethanol to obtain a powder of ethyl 2-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carboxylate (**7**) in 95% yield. Hydrazinolysis of (**7**) gave a powder of 2-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carbohydrazide (**8**) in 53% yield. Treatment of (**1**) with phenyl isothiocyanate afforded a solid product of 2-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-*N*-phenylhydrazinecarbothioamide (**9**) in 58% yield. A mixture of anhydrous sodium acetate in absolute ethanol was prepared to obtain (**9**), and finally phenacyl bromide and/or ethylbromoacetate were/was added to get a solid product of (2*E*)-3,4-diphenyl-1,3-thiazol-2(3*H*)-one (7,9-dimethylpyrido \[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)hydrazone (**10**) in 71% yield and (2*E*)-3-phenyl-1,3-thiazolidine-2,4-dione 2-\[(7,9-dimethylpyrido \[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)hydrazone\] (**11**) in 71% yield. A mixture of acetylacetone and/or ethylacetoacetate and (**1**) was refluxed in absolute ethanol to give 4-(3,5-dimethyl-1*H*-pyrazol-1-yl)-7,9-dimethylpyrido\[3′,2′:4,5\]thieno \[3,2-*d*\]pyrimidine (**12**) in 78% yield and 2-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-5-methyl-2,4-dihydro-3*H*-pyrazol-3-one (**13**) in 84% yield. The structures of (**2--13**) were established by infrared (IR) as well as proton nuclear magnetic resonance (^1^H NMR) spectra. All reactions are illustrated in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. Physical properties and structural data for the newly synthesized pyridothienopyrimidine derivatives are shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

![Synthesis of New Pyridothienopyrimidine Derivatives](ao0c00188_0002){#sch1}

###### Physical Properties and Structural Data for the Synthesized Compounds

  comp. no.   mp (°C)    yield (%)   mol. formula          MW (g/mol)
  ----------- ---------- ----------- --------------------- ------------
  **2**       127--129   58          C~15~H~11~N~7~S       321.36
  **3**       213--215   55          C~16~H~11~N~7~SO      349.37
  **4**       228--231   45          C~17~H~13~N~7~SO      363.40
  **5**       220--222   72          C~15~H~10~N~6~SO      322.34
  **6**       271--273   41          C~15~H~11~N~5~SO~3~   341.34
  **7**       203--205   95          C~17~H~15~N~5~SO~3~   369.40
  **8**       191--193   53          C~15~H~13~N~7~SO~2~   355.37
  **9**       181--183   58          C~18~H~16~N~6~S~2~    380.49
  **10**      207--209   71          C~26~H~20~N~6~S~2~    480.61
  **11**      181--183   71          C~20~H~16~N~6~S~2~O   420.51
  **12**      219--221   78          C~16~H~15~N~5~S       309.39
  **13**      237--239   84          C~15~H~12~N~5~SO      310.35

A screening for antibacterial activities of the newly synthesized pyridothienopyrimidine derivatives has been performed against three microorganisms ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

###### MIC (in μg/mL) of the Title Compounds[a](#t2fn1){ref-type="table-fn"}

  comp.        *B. subtilis* (Gram +ve)   *P. aeruginosa* (Gram −ve)   *Streptomyces* species (actinomycetes)
  ------------ -------------------------- ---------------------------- ----------------------------------------
  penicillin   31                         46                           33
  **2**        100                        125                          [b](#t2fn2){ref-type="table-fn"}
  **3**        100                        100                          250
  **4**        100                        250                          75
  **5**                                   75                           75
  **6**        75                         125                          100
  **7**        75                         100                          75
  **8**        75                         100                          75
  **9**        125                        500                          250
  **10**       250                                                     125
  **11**       75                                                      125
  **12**       125                        125                          500
  **13**       250                        125                           

The negative control DMSO showed no activity.

Totally inactive (MIC \> 500 μg/mL).

Materials and Methods {#sec3}
=====================

Synthetic Methods, Analytical and Spectral Data {#sec3.1}
-----------------------------------------------

A Büchi melting point apparatus was used to measure the newly synthesized pyridothienopyrimidine derivatives' melting points, which were uncorrected. A Bruker-Vector22 spectrometer (Bruker, Bremen, Germany) was used to record IR spectra (KBr). A Varian Gemini spectrometer (300 MHz, DMSO-*d*~6~) was used to record ^1^H NMR with tetramethylsilane (TMS) as an internal reference. The chemical shifts are expressed in δ scale (ppm) relative to TMS as a reference, and the coupling constants (*J* values) are given in hertz (Hz). Analytical thin layer chromatography was performed to monitor the progress of the reactions using aluminum silica gel 60 F245 plates (Merck, Darmstadt, Germany). Antimicrobial activities were screened at the College of Medicine, Dar Al Uloom University, Riyadh, Kingdom of Saudi Arabia.

Experimental Section {#sec4}
====================

5-Amino-1-(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-1*H*-pyrazole-4-carbonitrile (**2**) {#sec4.1}
---------------------------------------------------------------------------------------------------------------

A mixture of ethoxymethylene malononitrile (0.55 g, 4 mmol) and 4-hydrazino-7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidine (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol (30 mL) for 10 h. The resulting precipitate was filtered off with suction, washed with ethanol, and recrystallized from ethanol to give a colored powder of (**2**) (58%), mp 127--129 °C. IR (KBr) ν cm^--1^: 3350--3280 (NH~2~), 1940, 1888 (CH aliphatic), 2230 (C≡N) cm^--1^. ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.49, 2.60 (2s, 6H, 2CH~3~), 4.72 (br s, 2H, NH~2~), 7.32 (s, 1H, Ar-H), 8.15 (s, 1H, Ar-H), 9.11 (s, 1H, Ar-H).

1-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-1,5-dihydro-4*H*-pyrazolo\[3,4-*d*\]pyrimidin-4-one (**3**) {#sec4.2}
------------------------------------------------------------------------------------------------------------------------------

Nitrile derivative (**2**) (0.31 g, 1 mmol) was refluxed in 80% formic acid (10 mL) for 11 h and then poured on cold water. The solid product of (**3**) (55%) was collected after filtration with suction and recrystallized from ethanol, mp 213--215 °C. IR (KBr) ν cm^--1^: 2920, 2890 (CH aliphatic), 1680 (C=O), 3200 (NH). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.48, 2.56 (2s, 6H, 2CH~3~), 7.00 (s, 1H, Ar-H), 7.28 (s, 1H, Ar-H), 8.97 (s, 1H, Ar-H), 9.25 (br s, 1H, NH).

1-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-6-methyl-1,5-dihydro-4*H*-pyrazolo\[3,4-*d*\]pyrimidin-4-one (**4**) {#sec4.3}
---------------------------------------------------------------------------------------------------------------------------------------

Nitrile derivative (**2**) (0.31 g, 1 mmol) was refluxed in 80% acetic acid (10 mL) and HCl (0.5 mL) for 10 h and then poured on cold water. The solid product of (**4**) (45%) was collected after filtration with suction and recrystallized from ethanol, mp 228--231 °C. IR (KBr) ν cm^--1^: 2920, 2890 (CH aliphatic), 1680 (C=O), 3200 (NH). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.49, 2.51, 2.86 (3s, 9H, 3CH~3~), 6.17 (s, 1H, Ar-H), 7.11 (s, 1H, Ar-H), 8.20 (s, 1H, Ar-H), 9.10 (br s, 1H, NH).

2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carbonitrile (**5**) {#sec4.4}
-------------------------------------------------------------------------------------------------------------------------

A mixture of ethoxymethylene cyanoactate (0.68 g, 4 mmol) and (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol (30 mL) for 8 h. The resulting precipitate was filtered off with suction, washed with ethanol, and recrystallized from ethanol to give (**5**) (72%), mp 220--222 °C. IR (KBr) ν cm^--1^: 2980, 2975 (CH aliphatic), 1665 (C=O), 2120 (C≡N), 3320--3250 (NH). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.62, 2.97 (2s, 6H, 2CH~3~), 7.27, 7.81, 8.88 (3s, 3H, Ar-H), 9.14 (br s, 1H, NH).

2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carboxylic Acid (**6**) {#sec4.5}
----------------------------------------------------------------------------------------------------------------------------

Acid hydrolysis occurred for (**5**) (0.32 g, 1 mmol) which was refluxed in 10% sulfuric acid (10 mL) for 12 h. The reaction mixture was poured on cold water, filtered off with suction, and dried to obtain a powder of (**6**) (41%), mp 271--273 °C. IR (KBr) ν cm^--1^: 3300--3200 (NH, OH), 1670 (C=O).

Ethyl 2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carboxylate (**7**) {#sec4.6}
------------------------------------------------------------------------------------------------------------------------------

A mixture of diethyl ethoxymethylenemalonate (1.3 g, 6 mmol) and (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol (30 mL) for 15 h. The resulting precipitate was filtered off with suction, washed with ethanol, and recrystallized from ethanol to give a powder of (**7**) (95%), mp 203--205 °C. IR (KBr) ν cm^--1^: 3270 (NH); 1890, 1870 (CH aliphatic), 1730, 1680 (2C=O), 1590 (C=N). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 1.02 (t, 3H, *J* = 1.5 Hz, C*H*~*3*~CH~2~) 2.49, 2.58 (2s, 6H, 2CH~3~), 4.28 (q, 2H, *J* = 11 Hz, CH~3~C*H*~*2*~), 7.16 (s, 1H, Ar-H), 8.66 (s,1H, Ar-H), 9.87 (s, 1H, Ar-H).

2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-3-oxo-2,3-dihydro-1*H*-pyrazole-4-carbohydrazide (**8**) {#sec4.7}
---------------------------------------------------------------------------------------------------------------------------

A mixture of hydrazine hydrate (0.25 g, 5 mmol) and (**7**) (0.36 g, 1 mmol) was refluxed in absolute ethanol (30 mL) for 6 h. The reaction mixture was cooled, filtered off, and then dried to give a powder of (**8**) (53%), mp 191--193 °C. IR (KBr) ν cm^--1^: 3300--3200 (NH, NH~2~), 1670, 1663 (2C=O).

2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-*N*-phenylhydrazinecarbothioamide (**9**) {#sec4.8}
------------------------------------------------------------------------------------------------------------

A mixture of phenyl isothiocyanate (0.54 g, 4 mmol) and (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol for 6 h. The reaction mixture was cooled and then filtered off with suction to get a solid product of (**9**) (58%), mp 181--183 °C. IR (KBr) ν cm^--1^: 3310, 3270 (NH), 1610 (C=N), 1507 (C=S). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.49, 2.59 (s, 6H, 2CH~3~), 6.96--7.48 (m, 7H, Ar-H); 9.10 (br s, 1H, NH), 9.90 (br s, 1H, NH), 10.09 (br s, 1H, NH).

(2*E*)-3,4-Diphenyl-1,3-thiazol-2(3*H*)-one (7,9-Dimethylpyrido \[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)hydrazone (**10**) {#sec4.9}
-------------------------------------------------------------------------------------------------------------------------------

A mixture of anhydrous sodium acetate (0.33 g, 4 mmol) and absolute ethanol (10 mL) was prepared to obtain (**9**) (0.38 g, 1 mmol), and finally phenacyl bromide (0.22 g, 1 mmol) was added. The whole mixture was refluxed for 9 h. The mixture was cooled and then filtered off with suction to get a solid product of (**10**) (71%), mp 207--209 °C. IR (KBr) ν cm^--1^: 3306 (NH), 2950, 2910 (CH aliphatic), 1600, 1580 (C=C). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.43, 2.49 (2s, 6H, 2CH~3~), 6.68 (s, 1H, Ar-H), 6.95--8.00 (m, 12H, Ar-H).

(2*E*)-3-Phenyl-1,3-thiazolidine-2,4-dione 2-\[(7,9-dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)hydrazone\] (**11**) {#sec4.10}
-----------------------------------------------------------------------------------------------------------------------------------

A mixture of anhydrous sodium acetate (0.33 g, 4 mmol) and absolute ethanol (10 mL) was prepared to obtain (**9**) (0.38 g, 1 mmol), and finally ethylbromoacetate (0.29 g, 1 mmol) was added. The above mixture was refluxed for 9 h. The mixture was cooled and then filtered off with suction to get a solid product of (**11**) (71%), mp 181--183 °C. IR (KBr) ν cm^--1^: 3280 (NH), 2980, 2897 (CH aliphatic), 1650 (C=O), 1590 (C=N). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.49, 2.52 (2s, 6H, 2CH~3~), 4.16 (s, 2H, CH~2~), 6.96--8.00 (m, 7H, Ar-H), 10.03 (br s, 1H, NH).

4-(3,5-Dimethyl-1*H*-pyrazol-1-yl)-7,9-dimethylpyrido\[3′,2′:4,5\]thieno \[3,2-*d*\]pyrimidine (**12**) {#sec4.11}
-------------------------------------------------------------------------------------------------------

A mixture of acetylacetone (0.8 g, 8 mmol) and (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol (30 mL) for 7 h. The excess of ethanol was removed under reduced pressure. The resulting precipitate was filtered off with suction, washed with ethanol, and recrystallized from ethanol to give a colored powder of (**12**) (78%), mp 219--221 °C. IR (KBr) ν cm^--1^: 2950, 2980 (CH aliphatic), 1590 (C=N). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.29, 2.59, 2.85, 2.91 (4s, 12H, 4CH~3~), 6.28 (s, 1H, Ar-H), 9.04 (s, 1H, Ar-H).

2-(7,9-Dimethylpyrido\[3′,2′:4,5\]thieno\[3,2-*d*\]pyrimidin-4-yl)-5-methyl-2,4-dihydro-3*H*-pyrazol-3-one (**13**) {#sec4.12}
-------------------------------------------------------------------------------------------------------------------

A mixture of ethylacetoacetate (0.78 g, 6 mmol) and (**1**) (0.98 g, 4 mmol) was refluxed in absolute ethanol (30 mL) for 9 h. The resulting precipitate was filtered off with suction, washed with ethanol, and recrystallized from ethanol to give a powder of (**13**) (84%), mp 237--239 °C. IR (KBr) ν cm^--1^: 1997, 1899 (CH aliphatic), 1670 (C=O), 1650 (C=N). ^1^H NMR (DMSO-*d*~6~) δ in ppm: 2.08, 2.93, 2.58 (3s, 9H, 3CH~3~), 3.67 (s, 2H, CH~2~), 7.22 (s, 1H, Ar-H), 8.67 (s, 1H, Ar-H).

Antimicrobial Screening {#sec5}
=======================

Preparation of the Sample {#sec5.1}
-------------------------

Dimethyl sulfoxide (DMSO) (12.5%) solvent was used to dissolve each of the test compounds and standards at 500 μg/mL concentration. Further diluted compounds and standards were prepared at the required quantities in the test medium.

Microorganisms' Culture {#sec5.2}
-----------------------

Reference cultures of *Bacillus subtilis* (ATCC-6633) (Gram-positive), *Pseudomonas aeruginosa* (ATCC-27853) (Gram-negative), and *Streptomyces* species (actinomycetes) were supplied from the Microbiology Department, College of Medicine, Dar Al Uloom University, Riyadh, Kingdom of Saudi Arabia as the bacterial strains for determining antibacterial activities of the newly synthesized pyridothienopyrimidine derivatives. A Mueller--Hinton agar (MHA) medium (Oxoid Chemical Co., UK) was used to maintain the bacterial strains for 24 h at 37 °C. A formed layer of about 3--4 mm thickness was obtained by melting the medium on a water bath, inoculating with 0.5 mL of the culture of the specific microorganism and poured into sterile Petri dishes. The layer was allowed to cool and harden. With the aid of a cork-borer, cups of about 10 mm diameter were produced.^[@ref25]^

Agar Diffusion Technique {#sec5.3}
------------------------

Newly synthesized pyridothienopyrimidine derivatives were screened for their antibacterial activities against *B. subtilis* (Gram-positive), *P. aeruginosa* (Gram-negative), and *Streptomyces* species (actinomycetes) using MHA medium (17.5 g casein hydrolysate, 1.5 g soluble starch, and 1000 mL beef extract). A stock solution of each synthesized compound (500 μg/mL) in DMSO was prepared, and graded quantities of the test compounds were incorporated in the specified quantity of sterilized liquid MHA medium. Different concentrations of pyridothienopyrimidine derivatives in dimethylformamide were placed separately in cups in the agar medium. Overnight incubation was applied for all plates at 37 °C. The measurement of inhibition zones was performed after 24 h. The minimum inhibitory concentration (MIC) was defined as the intercept of the grave of logarithm concentrations versus diameter of the inhibition zones.^[@ref26],[@ref27]^

The antibacterial activities of the newly synthesized pyridothienopyrimidine derivatives have been screened against three microorganisms; *B. subtilis* (ATCC-6633) (Gram-positive), *P. aeruginosa* (ATCC-27853) (Gram-negative), and *Streptomyces* species (actinomycetes) ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

The results of the antibacterial activities screening have shown that compounds **6**, **7**, **8**, and **11** have the highest activity against *B. subtilis* with MIC values of 75 μg/mL followed by compounds **2**, **3**, and **4**. Compound **5** has the highest inhibition power against *P. aeruginosa*. Among the series of screened derivatives, compounds **4**, **5**, **7**, and **8** are the most active against *Streptomyces* species with MIC values of 75 μg/mL. In addition, there are compounds that have shown limited biological activities and others that have not had any antibacterial activity. The MIC values of all screened compounds are shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.
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